Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Association of multiple sclerosis susceptibility variants and early attack location in the CNS.
Placebo power.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
Immunohistochemical detection of sphingosine-1-phosphate and sphingosine kinase-1 in human tissue samples.
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
[Pharmacological properties and clinical efficacy of fingolimod hydrochloride (Imusera®/Gilenya®) for the treatment of multiple sclerosis].
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Transverse myelitis.
Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave Dreams Study (Brain Venous Drainage Exploited Against Multiple Sclerosis): study protocol for a randomized controlled trial.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
The natural course of clinically isolated syndrome in pediatric patients.
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
Concurrence of multiple sclerosis and amyotrophic lateral sclerosis in patients with hexanucleotide repeat expansions of C9ORF72.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.

Pages